| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 165.00K | — |
| Operating expense | — | — |
| Net income | -253.42M | 39.06% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2561.HK returned -57.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -39.1% |
| 1 year | -57.0% |
| All-time high | $53.15 (Mar 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2561.HK would be worth today ›No. VISEN Pharmaceuticals has not paid a dividend in the past 12 months.
VISEN Pharmaceuticals is part of the Healthcare sector.
VISEN Pharmaceuticals has a market cap of 2.27B HKD, based on the latest quote.